EUVIMEDEUVIMED entdecken
Crossref

β‐Cyclodextrin Inclusion Complex of d ‐Limonene: A Promising Biocompatible Formula for Enhanced Wound Healing—In Vitro and In Vivo Studies

Mostafa Fytory iD, Obaydah Abd Alkader Alabrahim iD, Abd Elrahman Abouzid, Jude Majed Lababidi, Amany A Aboomeirah, Jihad El-Qassas, Sara Tombelli, Osama M Ahmed iD, Nagwa El-Badri, Hassan Mohamed El-Said Azzazy iD

Journal of Biomedical Materials Research Part A · 2026

DOI: 10.1002/jbma.70016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2026. Verfasst von Mostafa Fytory und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Sciences & Engineering, The American University in Cairo, New Cairo, Egypt. Hauptthemen laut MEDLINE: Wound Healing, beta-Cyclodextrins, Biocompatible Materials, Cyclohexenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Science and Technology Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wound healing, a complex multifactorial process, continues to pose a challenge, justifying the search for innovative therapeutic approaches to accelerate recovery. In this study, β‐cyclodextrin‐encapsulated d ‐limonene (βCD‐ d ‐limonene) was formulated and investigated as a promising strategy for wound management. The inclusion complex was successfully synthesized via a simple approach and thoroughly characterized, confirming enhanced physicochemical stability, encapsulation efficiency, and thermal stability. The βCD‐ d ‐limonene nanoparticles exhibited a high encapsulation efficiency of 91.97% ± 3.42%. Antimicrobial assessments demonstrated significantly higher antibacterial efficacy of βCD‐ d ‐limonene compared to free d ‐limonene against both Gram‐positive and Gram‐negative bacteria. A significant 90‐fold decrease in the minimum inhibitory concentration (MIC) was recorded for the most susceptible bacterium, Pseudomonas aeruginosa ( P. aeruginosa ), with values decreasing from 111.2 mg/mL for free d ‐limonene to 1.24 mg/mL for the βCD‐ d ‐limonene complex. In vivo, wound healing studies revealed faster wound closure, reduced inflammation, and improved tissue regeneration. Gene expression analysis demonstrated modulation of key markers such as IL‐6, MMP3, BAX, VEGF, and TGF‐β1, supporting the inclusion complex's (βCD‐ d ‐limonene) role in regulating inflammation, apoptosis, and angiogenesis. Histological and immunohistochemical evaluations confirmed enhanced tissue architecture and cellular response in βCD‐ d ‐limonene‐treated mice. These results underscore the potential of βCD‐ d ‐limonene as a stable, biocompatible, and highly effective therapy, offering a natural platform for wound care and related biomedical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound Healingbeta-CyclodextrinsBiocompatible MaterialsCyclohexenesTerpenesLimoneneAnimalsMiceAnti-Bacterial AgentsMicrobial Sensitivity TestsMaleNanoparticlesHumansPseudomonas aeruginosa

Stichwörter der Autor:innen

biocompatibled‐limonenegene regulationin vivonanoparticleswound healingβ‐cyclodextrin

Substanzen

Limonenebeta-CyclodextrinsBiocompatible MaterialsCyclohexenesAnti-Bacterial AgentsTerpenesbetadex

Autor:innen und Institutionen

  • Department of Chemistry, School of Sciences & Engineering, The American University in Cairo, New Cairo, Egypt.
  • Material Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni-Suef, Egypt.
  • Istituto di Fisica Applicata Nello Carrara - CNR, Firenze, Italy.
  • Center of Excellence for Stem Cells and Regenerative Medicine, Zewail City of Science and Technology, Giza, Egypt.
  • Zoology Department, Faculty of Science, Zagazig University, Zagazig, Egypt.
  • Physiology Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt.

ORCID-Profile: Mostafa Fytory, Obaydah Abd Alkader Alabrahim, Osama M Ahmed, Hassan Mohamed El-Said Azzazy

Förderung

  • Science and Technology Development Fund

Zitieren

APA

Fytory, M., Alabrahim, O. A. A., Abouzid, A. E., Lababidi, J. M., Aboomeirah, A. A., El-Qassas, J., Tombelli, S., Ahmed, O. M., El-Badri, N., & Azzazy, H. M. E. (2026). β‐Cyclodextrin Inclusion Complex of d ‐Limonene: A Promising Biocompatible Formula for Enhanced Wound Healing—In Vitro and In Vivo Studies. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbma.70016

Vancouver

Fytory M, Alabrahim OAA, Abouzid AE, Lababidi JM, Aboomeirah AA, El-Qassas J, et al. β‐Cyclodextrin Inclusion Complex of d ‐Limonene: A Promising Biocompatible Formula for Enhanced Wound Healing—In Vitro and In Vivo Studies. Journal of Biomedical Materials Research Part A. 2026. doi:10.1002/jbma.70016

BibTeX
@article{Fytory2026,
  author = {Fytory, Mostafa and Alabrahim, Obaydah Abd Alkader and Abouzid, Abd Elrahman and Lababidi, Jude Majed and Aboomeirah, Amany A and El-Qassas, Jihad and Tombelli, Sara and Ahmed, Osama M and El-Badri, Nagwa and Azzazy, Hassan Mohamed El-Said},
  title = {β‐Cyclodextrin Inclusion Complex of d ‐Limonene: A Promising Biocompatible Formula for Enhanced Wound Healing—In Vitro and In Vivo Studies},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2026},
  doi = {10.1002/jbma.70016}
}
Kostenlos starten →